Rallybio Stock (NASDAQ: RLYB) stock price, news, charts, stock research, profile.
Open | - |
Close | - |
Volume / Avg. | 1.00 / 162.49K |
Day Range | - - - |
52 Wk Range | 1.08 - 5.00 |
Market Cap | $45.64M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 43 |
Short Interest | 1.87% |
Days to Cover | 7.13 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of Rallybio (NASDAQ:RLYB) through any online brokerage.
Other companies in Rallybio’s space includes: Syros Pharmaceuticals (NASDAQ:SYRS), Serina Therapeutics (AMEX:SER), HOOKIPA Pharma (NASDAQ:HOOK), Kezar Life Sciences (NASDAQ:KZR) and Fortress Biotech (NASDAQ:FBIO).
Rallybio has a consensus price target of $8.30.
The stock price for Rallybio (NASDAQ: RLYB) is $1.1 last updated September 19, 2024 at 4:57 PM EDT.
There are no upcoming dividends for Rallybio.
Rallybio’s Q3 earnings are confirmed for Thursday, November 7, 2024.
There is no upcoming split for Rallybio.
Rallybio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.